Ticker
RLYBCompany Name
RALLYBIO CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 51M | $ 58K | 0.11% |
3/31/2025 | $ 57.98M | $ 116K | 0.2% |
12/31/2024 | $ 68.11M | $ 154K | 0.23% |
9/30/2024 | $ 79.01M | $ 230K | 0.29% |
6/30/2024 | $ 92.43M | $ 284K | 0.31% |
3/31/2024 | $ 99.36M | $ 339K | 0.34% |
12/31/2023 | $ 115.62M | $ 392K | 0.34% |
9/30/2023 | $ 133.19M | $ 428K | 0.32% |
6/30/2023 | $ 147.58M | $ 479K | 0.32% |
3/31/2023 | $ 162.32M | $ 518K | 0.32% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for RALLYBIO CORP is calculated as follows: Debt [ $ 0 ] / Assets [ $ 141.86M ]
(=) Debt to Assets [ 0% ]
Minimum
Dec 31, 2020
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 4.37K |
---|---|
min | 0% |
max | 116.6% |
average | 26.33% |
median | 21.09% |
std | 24.49% |